1. Moreland LW. Intra-articular Hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther. 2003;56(2):54-67. 2003 Jan 14.
2. Uebelhart D, Williams JM. Effects of hyaluronic acid on cartilage degradation. Curr Opin Rheumatol. 1999 Sep;11(5):427-35.
3. Hirota W Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4, 6 keto-prostaglandin fialpha, prostaglandin F2 alpha and interleukin-1 beta in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. BRJ Oral Maxillofac surg 1998;36:3538.
4. Goa KL, Benfield P Hyaluronic Acid. A review of its pharmacology and use as a surgical aid in ophthalmology and its therapeutic potential in joint diseases and wound healing. Drugs. 1994 Mar;47(3):536-66.
5. Saari H. Konttinen YT, Tulamo RM, Antti-Poika I, Honkanen V Concentration and degree of polymerization of hyaluronate in equine synovial fluid. Am J Vet Res. 1989 Dec;50(12):2060-3.
6. Kang Y, Eger W, Koepp H, Williams JM, Kuettner KE, Homandberg GA. Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan syntheses. J Orthop Res. 1999 Nov;17(6):858-69.
7. Han F, Ishiguro N, Ito T, Sakai T, Iwata H. Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints Nagoya J Med Sci. 1999 Nov;62(3-4): 115-26.
8. Fukuda K, Dan H, Takayama M, Kumano F, Saitoh M, Tanaka S. Hyaluronic acid increases proteoglycan systhesis in bovine articular cartilage in the presence of interleukin-1. J Pharmacol Exp Ther. 1996 June;277(3):1672-5.
9. Schauss AG, Balogh L, Polyak A, Mathe D, Kiraly R, Janoki G. Absorption, distribution and excretion of 99mtechnetium labeled Hyaluronan after single oral doses in rats and beagle dogs FASEB J, Part1:A150-A151.
10. Turley EA, Asculai SS. Oral administration of effective amounts of forms of hyaluronic acid. US Patent 6537978B1
11. Weissmann B, Meyer K, Sampson, P and Linker A. Isolation of oligosaccharides enzymatically produced from hyaluronic acid. J Biol Chem;208(1):417-429.
12. Laurent, T.C. 1970. Structure of hyaluronic acid. In Chemistry and the Molecular Biology of the Intracellular Matrix, ed. E. A. Galazs, 703-732, London: Academic Press.
13. Laurent, T.C., and Fraser, J.R.E. 1992. Hyaluronan. FASEB J. 6:2397-2404.
14. Scott, J.E., and Heatley, F. 1999. Hyaluronan forms specific stable tertiary structures in aqueous solution: a C-13 NMR study. Proc. Natl. Acad. Sci. USA 96:4850-4855.
15. Sundblad, L. 1965. Glycosaminoglycans and glycoproteins in synovial fluid. In The Amino Sugars. The Chemistry and Biology of the Compounds Containing the Amino Sugars, eds. E.A. Balazs and R.W. Jeanloz, 229-250, New York: Academic Press.
16. Uhlin, L. 1997. Hyaluronan in skin. J. Intern. Med. 242:61-66.
17. Balazs, E.A. 1998. The visoelastic intracellular matrix and control of cell function by Hyaluronan. In The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, ed. T.C. Laurent, 185-204. London:Portland Press.
18. Miyazaki K, Goto S, Ogasawara H et al. 1984. Studies on analgesic and anti-inflammatory effects of sodium hyaluronate. Pharmacometrics. 228:1123-1135.
19. Matsuow K, Kimua H, Komatsu K et al. 1993. The scavenging effects of TMJ synovial fluids on the active oxygen generation. J of Jap Soc for Temporomandibular Junction. 5:1-9.
20. Sasaki T and Watanabe C. Stimulation of osteoinduction in bone wound healing by high molecular weight hyaluronan. Bone. 1995 Jan;16(1):9-15
21. Masellis A. Glycoforum Accessed 5/5/06. Available at www.glycoforum.gr.jp under hyaluronan
22. Pilitsis, JG, Lucas, DR, and Rengachary, SR. Bone Healing and Spinal Fusion. Neurosurg Focus. 2002;13(6). -5.
23. Huang, L, Cheng, YY, Koo, PL, Lee, KM, Qin, L, Cheng, JC, and Kumta, SM. The effect of Hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J Biomed Mater Res A. 2003;66(4):880-4.
24. Stancikova, M, Svik, K, Istok, R, Rovensky, J, and Velebny, V. The effects of Hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced ostopenia. Int J Tissue React. 2004;26(1-2):9-16.
25. Ding, M, Danielsen, CC, and Hvid, I. Effects of hyaluronan on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthritis. Bone. 2005;36(3):489-501.
26. Han F, Ishiguro N, Ito T, Sakai T, Iwata H. Effects of sodium hyaluronate on experimental osteoarthritis in rabbit knee joints Nagoya J Med Sci. 1999 Nov;62(3-4): 115-26.
27. McCarty, MF. Glucosamine for wound healing. Med Hypotheses. Oct;47(4):273
28. Dog Owner's Guide. Arthritis. Available at: www.canismajor.com/dog/arthrit.html. Accessed August 22, 2005.
29. Aviad AD, Houpt JB. The molecular weight of therapeutic Hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol. 1994 Feb;21(2)297-301.
30. The Daily Cat: Bringing up Kitty: A Healthy Cat. Osteoarthritis and your cat. Available at: www.catsplay.com/thedailycat/2002-06-07/bringing_healthy/osteoarthritis Accessed: October 11, 2005.
31. Nash, H. Arthritis. Available at: www.peteducation.com/article.cfm?cls=1&cat=1321&articleid=208 Accessed October 11, 2005.
32. Michigan State University Teaching Hospital site. Osteoarthritis. A vailable at cvm.msu.edu/vth/spe/arc/osteoarthritis.htm. Accessed August 18.2005
33. The Senior Dogs Project. RimadylTM Update. Available at www.srdogs.com/Pages/rimadylgdog.html. Accessed August 18, 2005.
34. Altman RD. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep. 2003 Feb;5(1):7-14 REVIEW
35. Hirota W Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4, 6 keto-prostaglandin fialpha, prostaglandin F2 alpha and interleukin-1 beta in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. BRJ Oral Maxillofac surg 1998;36:3538.
36. Kiburz, DW. Evaluation of MHB3 among Patients with Chronic Joint Symptoms 2007 (.PDF)
37. Welch, I, Hill, T. Evaluation of a Modified Hyaluronan Biopolymer (MHB3) on Cartilage Loss and Osteophyte Formation in a Knee Instability Model 2007 (.PDF)
38. Turley, E. Evaluation of MHB3 hyaluronan's Effects on Molecular Weight of Circulating Hyaluronan 2008 (.PDF)
39. Ma, J, Turley, E, Bhalla, A, Holdsworth, D, Granton, P. Evaluation of MHB3 on the Development of Osteopenia 2008 (.PDF)
40. Welch, I, Hill, T. Effects of a Modified Hyaluronan Biopolymer (MHB3) on Cartilage Loss in a Monoarthritis Model 2008 (.PDF)
41. Balogh, L, Polyak, A, Mathe, D, Kiraly, R, Thuroczy, J, Terez, M, Janoki, G, Ting, Y, Bucci, L, Schauss, A. Absorption, Uptake and Tissue Affinity of High-Molecular-Weight Hyaluronan after Oral Administration in Rats and Dogs. J. Agric. Food Cheml, 2008, 56(22), 10582-10593
42. Bucci, L, Turpin, A. Will the Real Hyaluronan Please Stand Up? J Appl Nutri, Vol 54;1,2004 (.PDF)
43. Weise, E. USA Today, Popular Supplement Fails Second Arthritis Test 2008, Sept 30
44. Pritzker, K.P.H. et al. Osteoarthritis and Cartilage 14,13 2006